Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012–2013
Author(s) -
Joshua G. Petrie,
Caroline Cheng,
Ryan E. Malosh,
Jeffrey J. VanWormer,
Brendan Flannery,
Richard K. Zimmerman,
Manjusha Gaglani,
Michael L. Jackson,
Jennifer P. King,
Mary Patricia Nowalk,
Joyce Benoit,
Anne Robertson,
Swathi Thaker,
Arnold S. Monto,
Suzanne E. Ohmit
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ952
Subject(s) - medicine , work productivity , respiratory illness , influenza vaccine , illness severity , respiratory system , intensive care medicine , productivity , severity of illness , immunology , emergency medicine , vaccination , economics , macroeconomics
Influenza causes significant morbidity and mortality, with considerable economic costs, including lost work productivity. Influenza vaccines may reduce the economic burden through primary prevention of influenza and reduction in illness severity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom